Beta Glucan Market Size, Growth Trends & Insights Analysis Report by Type (Soluble, Insoluble), by Application (Food & Beverages, Personal Care & Cosmetics, Pharmaceuticals, Animal Feed, Others), by Region, and Competitive Landscape Forecasts, 2024-2033

In 2024, the global Beta Glucan market was valued at USD 481.07 million, with a CAGR of 7.98% from 2024 to 2033.

Beta Glucan is a polysaccharide composed of glucose monomers naturally found in bacteria, fungi, algae and cereals, including β-1,3 / 1,6 in yeast and mushroom glucan, and β-1,3 / 1,4 in oat and barley glucan. Beta glucan has a variety of biological effects, such as immune-enhancing and antioxidant.

Global Beta Glucan Market Size (M USD) and CAGR 2024-2033

The global Beta Glucan market is experiencing robust growth, driven by several key factors. One of the primary drivers is the increasing awareness of health and nutrition among consumers. The demand for functional foods and supplements that enhance immune health has surged in recent years, and Beta Glucan, with its immune-enhancing and antioxidant properties, has become a popular ingredient.

Another significant driver is the regulatory support and approval of Beta Glucan in various countries. Governments and regulatory bodies, such as the FDA in the United States and the EFSA in Europe, have recognized the health benefits of Beta Glucan and permitted its use in a wide range of products, including food, beverages, dietary supplements, and pharmaceuticals. This regulatory approval has expanded the market potential for Beta Glucan and provided a foundation for its growth.

The market is also benefiting from effective marketing strategies. Companies are leveraging social media and other digital platforms to educate consumers about the benefits of Beta Glucan and its applications. This has increased consumer awareness and trust, leading to higher adoption rates of Beta Glucan products.

Despite the promising growth prospects, the Beta Glucan market faces several challenges and restraints. One of the primary challenges is regulatory compliance. Governments are increasingly stringent in their regulation of food safety and environmental protection, placing higher demands on the Beta Glucan industry. This has led to increased responsibility and security investments for companies, particularly in Europe and China, where regulations are particularly strict.

Another restraint is the limited application scenarios for Beta Glucan. While it is generally considered safe, there are concerns that it may lower blood glucose levels, restricting its use in certain populations, such as those with hypoglycemia or those taking medications that lower blood sugar.

The market also faces challenges related to the extraction and processing of Beta Glucan. The physicochemical properties of Beta Glucan can change during processing, which may affect its biological activity and health benefits. This requires careful handling and processing to maintain its efficacy, adding complexity and cost to production.

Soluble Beta Glucan is characterized by its ability to dissolve in water, making it highly versatile for a wide range of applications. In 2024, the market value for Soluble Beta Glucan is forecasted to be 311.45 million USD. This type is predominantly derived from cereals such as oats and barley, as well as seaweed. Its solubility allows it to be easily incorporated into food and beverage products, dietary supplements, and personal care items.

Insoluble Beta Glucan, on the other hand, is derived mainly from yeast and mushrooms. It is known for its robust structure and is less soluble in water. In 2024, the market value for Insoluble Beta Glucan is projected to be 169.62 million USD. This type is particularly effective in applications where its insoluble nature provides specific benefits.

Type

Market Size (M USD) 2024

Soluble

311.45

Insoluble

169.62

The Food & Beverages sector is the largest application area for Beta Glucan, with a projected market value of 224.15 million USD in 2024. This segment includes a wide range of products such as oatmeal, cereals, functional beverages, and dietary supplements. Beta Glucan is particularly valued for its ability to enhance the nutritional profile of these products by providing health benefits like cholesterol reduction and improved immune function. The increasing consumer demand for health-conscious and functional foods is driving the growth of Beta Glucan in this sector.

The Personal Care & Cosmetics industry is another significant application area for Beta Glucan, with a projected market value of 79.90 million USD in 2024. Beta Glucan is used in creams, lotions, serums, and other skincare products for its anti-aging properties. It helps in skin restructuring, reducing wrinkles, and providing a natural moisture barrier. The growing awareness of skin health and the increasing demand for natural and effective skincare ingredients are driving the adoption of Beta Glucan in this sector.

The Pharmaceuticals sector is also a notable application area for Beta Glucan, with a projected market value of 71.30 million USD in 2024. Beta Glucan is used in various pharmaceutical formulations for its immune-modulating effects. It is incorporated into vaccines, advanced wound care products, and other medical formulations to enhance immune response and support overall health. The increasing focus on natural and effective health supplements is driving the growth of Beta Glucan in this sector.

The Animal Feed industry is another key application area for Beta Glucan, with a projected market value of 78.49 million USD in 2024. Beta Glucan is used as a natural immune booster in animal feed, enhancing the health and performance of livestock. It helps in improving feed conversion ratios and reducing mortality rates, making it a valuable ingredient in the animal feed industry. The growing demand for natural and effective animal health solutions is driving the adoption of Beta Glucan in this sector.

Application

Market Size (M USD) 2024

Food & Beverages

224.15

Personal Care & Cosmetics

79.90

Pharmaceuticals

71.30

Animal Feed

78.49

Others

27.22

North America is a significant market for Beta Glucan, with a projected market value of 155.06 million USD in 2024. The region benefits from a strong demand for health and wellness products, particularly in the United States and Canada. The presence of major players and advanced research facilities also supports the growth of the Beta Glucan market in this region. The increasing consumer awareness of health benefits and the growing demand for natural supplements are driving the market in North America.

Europe is the largest market for Beta Glucan, with a projected market value of 175.41 million USD in 2024. The region has a strong regulatory framework and a high demand for natural and effective health products. The presence of major manufacturers and a well-established supply chain also contribute to the growth of the Beta Glucan market in Europe. The increasing focus on health and wellness, particularly in countries like Germany and the United Kingdom, is driving the demand for Beta Glucan in this region.

China is a rapidly growing market for Beta Glucan, with a projected market value of 69.51 million USD in 2024. The region benefits from a large consumer base and increasing demand for health and wellness products. The growing middle class and increasing disposable income are driving the adoption of Beta Glucan in various applications. The government’s focus on improving healthcare infrastructure and supporting the development of the health industry also contribute to the growth of the Beta Glucan market in China.

Global Beta Glucan Market Size by Region in 2024

Company Profile:

Kerry is a leading global food company headquartered in Ireland, established in 1972. The company operates across the Americas and has a global sales presence. Kerry is divided into several business areas, including ingredients and flavors, consumer foods, and agribusiness. The company is known for its innovative and sustainable approach to food production, focusing on delivering high-quality products to consumers worldwide.

Business Overview:

Kerry’s business is centered around providing natural and functional ingredients for the food and beverage industry. The company’s Wellmune product, a baker’s yeast beta 1,3/1,6 glucan, is clinically proven to enhance immune health. Kerry’s commitment to innovation and sustainability has positioned it as a leader in the Beta Glucan market.

Product Introduction:

Kerry’s Wellmune is a natural food, beverage, and supplement ingredient that supports immune health. It is a patented and award-winning product, available in two powder forms suitable for various applications. Wellmune is Kosher, Halal, gluten-free, non-allergenic, non-GMO, and organic compliant, making it a versatile and safe choice for consumers.

Recent Financial Performance:

In the most recent year, Kerry’s Beta Glucan production reached 1,189.7 tons, with a production value of 57.65 million USD.

Company Profile:

DSM NV, established in 1902, is a global science-based company headquartered in the Netherlands. The company operates primarily in Europe and has a worldwide sales presence. DSM is known for its innovative solutions in nutrition, health, and sustainable living, focusing on delivering value to stakeholders through sustainable practices.

Business Overview:

DSM NV’s business is centered around providing innovative solutions for human nutrition, animal nutrition, personal care, and aroma. The company’s OatWell product, a bioactive oat beta-glucan, is known for its cholesterol-lowering properties and versatility in food applications. DSM’s commitment to sustainability and innovation has solidified its position as a leader in the Beta Glucan market.

Product Introduction:

DSM NV’s OatWell is a natural and highly versatile powder that can be used in a wide range of applications, including breads, biscuits, cereals, powder drinks, and dietary supplements. OatWell is clinically proven to reduce blood cholesterol levels and maintain healthy blood glucose, making it a valuable ingredient for health-conscious consumers.

Recent Financial Performance:

In the most recent year, DSM NV’s Beta Glucan production reached 1,841.3 tons, with a production value of 53.86 million USD.

Company Profile:

Angel Yeast, established in 1986, is a high-tech listed company headquartered in China. The company operates primarily in Asia and has a global sales presence. Angel Yeast is known for its expertise in yeast and biotechnology, focusing on delivering high-quality products for various industries.

Business Overview:

Angel Yeast’s business is centered around providing yeast and biotech solutions for the food, nutrition, and health sectors. The company’s Fubon Yeast β-Glucan is a concentrated beta glucan derived from the cell wall of specially fermented Saccharomyces cerevisiae. Angel Yeast’s commitment to innovation and quality has positioned it as a leader in the Beta Glucan market.

Product Introduction:

Angel Yeast’s Fubon Yeast β-Glucan is a biological response stimulator that enhances immune defenses against viral, bacterial, and fungal invaders. It is particularly effective in improving the health and performance of aquaculture and livestock. Fubon Yeast β-Glucan is a versatile product that supports overall health and well-being.

Recent Financial Performance:

In the most recent year, Angel Yeast’s Beta Glucan production reached 800.5 tons, with a production value of 39.49 million USD.

Share your love
en_USEnglish